Monograph Details
|
|
Eye Disorders
> Ocular infections
|
|
CILOXAN |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Quinolone. |
| Generic Name |
|
Ciprofloxacin (as HCl) 0.3%; oph. soln; contains benzalkonium chloride. |
| Also |
|
• CILOXAN OPH OINT
|
| Indications |
|
Susceptible infections of conjunctiva and cornea. |
| Adults and Children |
|
<1 year: not recommended. ≥1 year: Conjunctivitis: 1–2 drops in conjunctival sac(s) every 2 hours while awake for 2 days, then 1–2 drops every 4 hours while awake for next 5 days. Corneal ulcers: 2 drops every 15 minutes for 1st 6 hours, then 2 drops every 30 minutes for rest of 1st day; 2nd day: 2 drops every 1 hour; 3rd–14th days: 2 drops every 4 hours. May treat for 14 days or until corneal reepithelialization occurs. |
| Precautions |
|
CNS or convulsive disorders. Discontinue if rash occurs. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
May increase theophylline levels. May potentiate oral anticoagulants. May increase renal toxicity with cyclosporine. |
| Adverse Reactions |
|
Soln: Burning, crystalline precipitates, lid margin crusting, scales, foreign body sensation, pruritus, conjunctival hyperemia, bad taste. Oint: ocular discomfort, blurred vision; may delay corneal healing. Both: superinfection. |
| How Supplied |
Soln—2.5 mL, 5 mL, 10 mL
Oint—3.5 g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
